Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate

NACompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

May 12, 2025

Conditions
Hypertension
Interventions
OTHER

E3 Remote Monitoring and Social Intervention

Patients are enrolled in a 12 week remote blood pressure monitoring program composed of a community health worker, nurse, pharmacist and social worker. Participants will receive a home cellular blood pressure cuff for remote monitoring and will receive tele-health calls from their community health worker to assist with blood pressure taking technique and adherence, medication adherence, education around diet and activity. Social work is available to provide institutional and community resources to patients with social needs. Patients will be screened pre intervention and post intervention for medication adherence and social determinants of health needs. The team nurse monitors and triages home blood pressures on the remote portal. The pharmacist assists with medication reconciliation, adherence, and titration of medications according to standards or care.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Rush University Medical Center

OTHER